Recent studies suggested that heart fatty acid-binding protein (HFABP or FABP3), a lipid-binding protein facilitating the intracellular transport of fatty acids, may contribute to AD diagnosis and prognosis in the earliest stages (Rosén et al., 2011). This evidence concerns the gene GOT2 and Alzheimer disease.